BIOMARKERS, GENES, AND TARGETS
Live / Allowed — Approved for publication (as of 30 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99251145
- Mark type
- Stylized text
- Filed
- 24 Jun 2025
- Attorney of record
- Michelle Bolos
Goods and services
- Class 041 — Education and entertainment services: Arranging and conducting of educational conferences in the field of healthcare
Owner
- Innovative Oncology Consulting, LLC, Deerfield, IL, US
Prosecution history
- 30 Mar 2026 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 30 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 30 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 30 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 30 Mar 2026 — USE AMENDMENT ACCEPTED
- 16 Mar 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 16 Mar 2026 — USE AMENDMENT FILED
- 16 Mar 2026 — TEAS AMENDMENT OF USE RECEIVED
- 13 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 13 Mar 2026 — FINAL REFUSAL E-MAILED
- 13 Mar 2026 — FINAL REFUSAL WRITTEN
- 23 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED